OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
January 27, 2011
Reflecting the manufacturing restructuring ongoing in the bio/pharmaceutical industry, Amgen and sanofi-aventis announced the sale of manufacturing facilities to contract manufacturers.
January 20, 2011
Merck Teams with Parexel; Roche CFO to Retire; and More
January 06, 2011
Gilead Sciences to Acquire Arresto Biosciences; Sartorius Appoints Head of Lab Business; and More.
January 02, 2011
Contract manufacturers strengthen their toolboxes and partnerships as they navigate the changing drug-development model.
The European Commission and Medicines Agency seem to be moving in advance of their ICH partners to update standards.
Expert and implementation working groups harmonize more guidelines and move Q11 forward.
Industry executives share insight into the future direction of drug manufacturing and the supply chain. This article contains online bonus material.
Top priorities for manufacturers include user fees, new health initiatives, and regulatory compliance.
Capable of great works, pharma as a whole still yields to the lesser angels of its nature.
A Q&A with Spectrum Laboratories President Tony MacDonald.